CytomX Therapeutics CTMX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's deferred tax assets and other non-current assets?
- CytomX Therapeutics (CTMX) reported deferred tax assets and other non-current assets of $31K in Q1 2026.
- How has CytomX Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- CytomX Therapeutics's deferred tax assets and other non-current assets decreased by 49.2% year-over-year, from $61K to $31K.
- What is the long-term trend for CytomX Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's deferred tax assets and other non-current assets has grown at a -57.3% compound annual growth rate (CAGR), from $2.17M to $31K.